AVEO Trademark

Trademark Overview

On Friday, January 20, 2012, a trademark application was filed for AVEO with the United States Patent and Trademark Office. The USPTO has given the AVEO trademark a serial number of 85520940. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 10, 2023. This trademark is owned by AVEO Pharmaceuticals, Inc.. The AVEO trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer
aveo

General Information

Serial Number85520940
Word MarkAVEO
Filing DateFriday, January 20, 2012
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 10, 2023
Registration Number4198292
Registration DateTuesday, August 28, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2012

Trademark Statements

Goods and ServicesMedicinal preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 25, 2012
Primary Code005
First Use Anywhere DateWednesday, November 29, 2006
First Use In Commerce DateWednesday, November 29, 2006

Trademark Owner History

Party NameAVEO Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02108
Party NameAVEO Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAVEO Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 10, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, January 10, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, January 10, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 10, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 22, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, August 28, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, March 23, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 23, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, March 23, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 14, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 14, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, August 28, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 29, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 29, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 28, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, June 12, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 30, 2012ASSIGNED TO EXAMINER
Wednesday, January 25, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2012NEW APPLICATION ENTERED

Related Keywords

aveo preparations cancer treatment oncology medicinal pharmaceutical